SAKARPharmaceuticals
Sakar Healthcare Ltd — Cash Flow Statement
₹498.45
-2.69%
Sakar Healthcare Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 1.75 Cr | -35.09 Cr | -48.85 Cr | -10.91 Cr | — |
| Repayment Of Debt | -1.36 Cr | -43.27 Cr | 0.00 | -1.96 Cr | — |
| Issuance Of Capital Stock | 5.76 Cr | 77.42 Cr | 33.35 Cr | 7.88 Cr | — |
| Capital Expenditure | -32.28 Cr | -59.56 Cr | -82.20 Cr | -35.55 Cr | — |
| End Cash Position | 0.31 Cr | 0.47 Cr | 0.09 Cr | 10.13 Cr | — |
| Beginning Cash Position | 0.46 Cr | 0.09 Cr | 0.03 Cr | 0.30 Cr | — |
| Changes In Cash | -0.16 Cr | 0.37 Cr | 0.06 Cr | 9.84 Cr | — |
| Financing Cash Flow | -3.48 Cr | 27.44 Cr | 41.10 Cr | 32.03 Cr | — |
| Interest Paid Cff | -7.82 Cr | -6.64 Cr | -5.42 Cr | -1.90 Cr | — |
| Net Common Stock Issuance | 5.76 Cr | 77.42 Cr | 33.35 Cr | 7.88 Cr | — |
| Common Stock Issuance | 5.76 Cr | 77.42 Cr | 33.35 Cr | 7.88 Cr | — |
| Net Issuance Payments Of Debt | -1.36 Cr | -43.27 Cr | 13.22 Cr | 26.05 Cr | — |
| Net Long Term Debt Issuance | -1.36 Cr | -43.27 Cr | 13.22 Cr | 28.02 Cr | — |
| Long Term Debt Payments | -1.36 Cr | -43.27 Cr | -85.01 Cr | -43.42 Cr | — |
| Investing Cash Flow | -30.71 Cr | -51.54 Cr | -74.38 Cr | -46.83 Cr | — |
| Net Other Investing Changes | 1.57 Cr | 4.89 Cr | 4.02 Cr | -11.29 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 3.14 Cr | 3.80 Cr | 0.00 | — |
| Sale Of Investment | 0.00 | 3.14 Cr | 3.80 Cr | 0.00 | — |
| Net PPE Purchase And Sale | -32.28 Cr | -59.56 Cr | -82.20 Cr | -35.55 Cr | — |
| Purchase Of PPE | -32.28 Cr | -59.56 Cr | -82.20 Cr | -35.55 Cr | — |
| Operating Cash Flow | 34.03 Cr | 24.47 Cr | 33.34 Cr | 24.64 Cr | — |
| Taxes Refund Paid | -2.37 Cr | -3.15 Cr | -4.27 Cr | -0.73 Cr | — |
| Change In Working Capital | -14.08 Cr | -13.18 Cr | 0.60 Cr | -2.55 Cr | — |
| Change In Other Current Liabilities | 10.42 Cr | 3.48 Cr | 13.76 Cr | 2.78 Cr | — |
| Change In Other Current Assets | 8.40 Cr | -7.57 Cr | 0.12 Cr | -3.47 Cr | — |
| Change In Payable | -6.39 Cr | 1.37 Cr | -4.42 Cr | 2.59 Cr | — |
| Change In Inventory | -15.86 Cr | -12.33 Cr | -1.21 Cr | -0.48 Cr | — |
| Change In Receivables | -9.83 Cr | 1.15 Cr | -7.91 Cr | -4.14 Cr | — |
| Other Non Cash Items | 7.72 Cr | 6.54 Cr | 5.47 Cr | 0.84 Cr | — |
| Provisionand Write Offof Assets | 0.02 Cr | 0.01 Cr | 0.02 Cr | 29000.00 | — |
| Depreciation And Amortization | 20.88 Cr | 18.05 Cr | 14.99 Cr | 8.06 Cr | — |
| Depreciation | 20.88 Cr | 18.05 Cr | 14.99 Cr | 8.06 Cr | — |
| Gain Loss On Sale Of PPE | 0.34 Cr | 0.00 | — | — | — |
| Net Income From Continuing Operations | 21.53 Cr | 15.90 Cr | 16.88 Cr | 19.01 Cr | — |
| Issuance Of Debt | — | 0.00 | 98.23 Cr | 93.71 Cr | 38.12 Cr |
| Other Cash Adjustment Outside Changein Cash | — | 21000.00 | 1000.00 | — | 1000.00 |
| Net Short Term Debt Issuance | — | 0.00 | 0.00 | -1.96 Cr | -1.96 Cr |
| Short Term Debt Payments | — | 0.00 | 0.00 | -1.96 Cr | -1.96 Cr |
| Long Term Debt Issuance | — | 0.00 | 98.23 Cr | 93.71 Cr | 38.12 Cr |
| Purchase Of Investment | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Amortization Cash Flow | — | 0.10 Cr | — | 0.73 Cr | 2.55 Cr |
| Pension And Employee Benefit Expense | — | -0.15 Cr | -0.21 Cr | — | — |
| Gain Loss On Investment Securities | — | 0.29 Cr | -0.13 Cr | -0.12 Cr | — |
| Net Other Financing Charges | — | — | -1000.00 | -1000.00 | — |
| Sale Of PPE | — | — | — | 14.19 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sakar Healthcare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.